Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Mass Cytometry of Acute Myeloid Leukemia Captures Early Therapy Response in Rare Cell Subsets

Paul Brent Ferrell, MD, Kirsten E. Diggins, Hannah G. Polikowsky, Jonathan M. Irish, PhD

Blood (2014) 124 (21): 2381.

https://doi.org/10.1182/blood.V124.21.2381.2381

Published: 2014

Journal Articles

Potentiated B-Cell Antigen Receptor Signaling In Mantle Cell Lymphoma Is Associated With Overexpression Of Surface CD79B and IgM

June Helen Myklebust, PhD, Joshua Brody, MD, Ash A. Alizadeh, MD, PhD, Debra K Czerwinski, Arne Kolstad, MD, PhD, Michael R Green, Ph.D., Roch Houot, MD, PhD, Jan Delabie, MD, PhD, Holbrook E Kohrt, MD, PhD, Jonathan M. Irish, PhD, Ronald Levy, MD

Blood (2013) 122 (21): 1768.

https://doi.org/10.1182/blood.V122.21.1768.1768

Published: 2013

Journal Articles

A Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma Chain Cytokine Signaling.

June H Myklebust, PhD, Jonathan M Irish, PhD, Roch Houot, MD, Joshua Brody, MD, Debra K Czerwinski, Ash A Alizadeh, MD, PhD, Arne Kolstad, MD, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 759.

https://doi.org/10.1182/blood.V114.22.759.759

Published: 2009

Journal Articles

Distinct Signaling Profiles and Drug Responses Identify Subpopulations of Pediatric T-Cell Acute Lymphoblastic Leukemia and Lymphoma Patients.

Jason Law, MD, Kristin Ammon, MD, Matt Zinter, Jason Wen, Brian Cook, Jonathan M Irish, PhD, Michelle L. Hermiston, MD, PhD

Blood (2009) 114 (22): 1595.

https://doi.org/10.1182/blood.V114.22.1595.1595

Published: 2009

Journal Articles

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma.

Roch Houot, MD, Matthew J Goldstein, Holbrook E Kohrt, MD, June H Myklebust, PhD, Ash A Alizadeh, MD, PhD, Jack T Lin, PhD, Jonathan M Irish, PhD, James A Torchia, Arne Kolstad, MD, PhD, Lieping Chen, MD, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 722.

https://doi.org/10.1182/blood.V114.22.722.722

Published: 2009

Journal Articles

Signaling Diversity in Human Lymphoma B Cells and in Tumor Infiltrating T Cells Correlates with Follicular Lymphoma Patient Clinical Outcomes

Jonathan M. Irish, PhD, Roch Houot, MD, June H. Myklebust, PhD, Debra K. Czerwinski, Garry P. Nolan, PhD, Ronald Levy, MD

Blood (2008) 112 (11): 377.

https://doi.org/10.1182/blood.V112.11.377.377

Published: 2008

Journal Articles

A Profile of 648 Signaling Network Events Identifies Cell Subsets with Diverse, Abnormal Responses to Lymphocyte Stimuli within Follicular Lymphoma Tumors.

Jonathan M. Irish, PhD, Faye Y. Hsu, Ph.D., Jeff P. Sharman, M.D., Roch Houot, M.D., Joshua D. Brody, M.D., Debra K. Czerwinski, Garry P. Nolan, Ph.D., Ronald Levy, M.D.

Blood (2007) 110 (11): 356.

https://doi.org/10.1182/blood.V110.11.356.356

Published: 2007

Journal Articles

A Novel Assay for Juvenile Myelomonocytic Leukemia Based on Aberrant Signaling Networks Measured Via Phospho-Specific Flow Cytometry Reduces Diagnosis Time from Weeks to Days.

Nikesh Kotecha, Nikki J. Flores, Jonathan M. Irish, PhD, Debbie Sakaguchi, MD, Sophie Archambeault, Ernesto Diaz-Flores, PhD, Marc Coram, PhD, Kevin M. Shannon, MD, Garry P. Nolan, PhD, Mignon L. Loh, MD

Blood (2007) 110 (11): 546.

https://doi.org/10.1182/blood.V110.11.546.546

Published: 2007

Journal Articles

Rapid, Sustained B Cell Receptor Signaling in Lymphoma B Cells Differs from Normal Signaling in Tumor Infiltrating Nonmalignant B Cells.

Jonathan M. Irish, PhD, Debra K. Czerwinski, Garry P. Nolan, PhD, Ronald Levy, MD

Blood (2005) 106 (11): 283.

https://doi.org/10.1182/blood.V106.11.283.283

Published: 2005

Journal Articles

Multiparameter Flow Cytometric Analysis Reveals Aberrant Phosphorylation of a Network of Effector Molecules in Defined Populations of Kras Mutant Bone Marrow.

Margaret E.M. Van Meter, BA, Ernesto Diaz-Flores, PhD, Joehleen A. Archard, BS, Nikesh Kotecha, BS, Amit J. Sabnis, BS, Jonathan M. Irish, PhD, Garry P. Nolan, PhD, Kevin M. Shannon, MD, Benjamin S. Braun, MD, PhD

Blood (2005) 106 (11): 239.

https://doi.org/10.1182/blood.V106.11.239.239

Published: 2005

NARROW

Mass Cytometry of Acute Myeloid Leukemia Captures Early Therapy Response in Rare Cell Subsets

Potentiated B-Cell Antigen Receptor Signaling In Mantle Cell Lymphoma Is Associated With Overexpression Of Surface CD79B and IgM

A Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma Chain Cytokine Signaling.

Distinct Signaling Profiles and Drug Responses Identify Subpopulations of Pediatric T-Cell Acute Lymphoblastic Leukemia and Lymphoma Patients.

Therapeutic Potential of Anti-CD137 Antibody in Lymphoma.

Signaling Diversity in Human Lymphoma B Cells and in Tumor Infiltrating T Cells Correlates with Follicular Lymphoma Patient Clinical Outcomes

A Profile of 648 Signaling Network Events Identifies Cell Subsets with Diverse, Abnormal Responses to Lymphocyte Stimuli within Follicular Lymphoma Tumors.

A Novel Assay for Juvenile Myelomonocytic Leukemia Based on Aberrant Signaling Networks Measured Via Phospho-Specific Flow Cytometry Reduces Diagnosis Time from Weeks to Days.

Rapid, Sustained B Cell Receptor Signaling in Lymphoma B Cells Differs from Normal Signaling in Tumor Infiltrating Nonmalignant B Cells.

Multiparameter Flow Cytometric Analysis Reveals Aberrant Phosphorylation of a Network of Effector Molecules in Defined Populations of Kras Mutant Bone Marrow.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only